Oramed Pharmaceuticals Incis A Biotech Company Based In Jerusalemisraelwith Additional Operations In New York Cityfounded In 2006The Company Specializes In Oral Drug Delivery Systemsaiming To Convert Injectable Treatments Into Oral Therapies Through Its Proprietary Protein Oral Deliverypodtechnologythis Innovation Focuses On Improving Diabetes Management And Enhancing Patient Complianceparticularly For Those With Type 2 Diabetes Who May Avoid Insulin Injections The Company S Product Pipeline Includes Ormd 0801An Oral Insulin Capsule Designed For Type 2 Diabetesand Ormd 0901An Oral Exenatide Capsule For Blood Sugar Regulationoramed Is Also Exploring The Use Of Oral Insulin For Treating Non Alcoholic Steatohepatitisnashand Has Established A Subsidiaryoravax Medicalto Develop An Oral Covid 19 Vaccinethe Pod Platform Protects Therapeutic Proteinsallowing For Systemic Absorption And Potential Applications In Various Protein Based Therapies
No conferences found for this company.
| Company Name | Oramed Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
